Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Based on the great success of the Essentials for Clinicians book series, focusing so far mostly on distinct solid cancer entities, the European Society for Medical Oncology (ESMO) has decided to extend this series further, presenting now the “Leukaemia & Myeloma” Essentials. This volume is published at the right time, as we are facing tremendous progress not only in understanding the biology but also in the clinical management of these diseases. Based on increasingly refined molecular diagnostics and accessibility to a plethora of new drugs targeting specific surface proteins or signal transduction pathways, personalised treatment is no longer only a vision but takes place in our daily clinical life. However, this great success substantially diversifies treatment approaches. In this situation, books such as this Essentials for Clinicians, which presents basic knowledge as well as deeper insight into novel therapeutic developments, are of immense value. Besides acute leukaemias and multiple myeloma, this volume also covers chronic myeloid leukaemia, myelodysplastic syndromes, myeloproliferative neoplasms and amyloidosis, thereby providing a comprehensive overview about leukaemias and myeloma as well as related or associated diseases. It informs the reader about biology, classification and treatment, including symptomatic therapy and management of complications. The concept to divide information into “What every oncologist/haematologist should know” and “More advanced knowledge” is brilliant and through this will address young as well as advanced haematologists/oncologists.

This Essentials for Clinicians, edited by the internationally recognised experts Drs Veronika Ballová, Michele Ghielmini and Meletios-Athanasios Dimopoulos, is an asset for the clinician dealing with haematological malignancies and will help to care for our patients in an optimal way.

Professor Christian Buske
Ulm, Germany

Editors and Contributors Chapter 1 – Diagnosis and classification of leukaemias

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.